Pharmaceuticals

Sanofi in pact to acquire US biotech haemophila drugs maker Bioverativ for 11.6 bn

22 Jan 2018

Biocon, Sandoz ink global pact for immunology, oncology biosimilar

19 Jan 2018

Both companies will share responsibility for end-to-end development, manufacturing and global regulatory approvals for a number of products and will have a cost and profit share arrangement globally

Pfizer to end Alzheimer, Parkinson research; patients disappointed

17 Jan 2018

Celgene Corp in talks to buy Juno Therapeutics

17 Jan 2018

In urban streams, pharmaceutical pollution is driving microbial resistance

11 Jan 2018

Pfizer to end research to develop new drugs for Alzheimer’s and Parkinson’s disease

09 Jan 2018

Celgene to Acquire Impact Biomedicines for upto $7 bn

08 Jan 2018

Luxturna gene therapy to cure rare blindness

05 Jan 2018

Bharat Biotech scores big with WHO-approved typhoid vaccine

04 Jan 2018

Typbar TCV, a fourth generation vaccine against typhoid disease, has proven to provide long term protection against typhoid to both adults and children below 2 years of age